Cox-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells

Apoptosis

Volumn 8, Issue 6, 2003, Pages 649-654

  Agarwal, Banke ^a   Swaroop, P ^b   Protiva, P ^c   Raj, S V ^d   Shirin, H ^c   Holt, P R ^c  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Howard Hughes Medical Institute   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; Chemoprevention; Colon cancer; Curcumin; Cyclooxygenase

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; CELECOXIB; CURCUMIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC SULFIDE; SULINDAC SULFONE;

APOPTOSIS; ARTICLE; CANCER CELL; CELL COUNT; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SELECTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET CELL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; COLONIC NEOPLASMS; CURCUMIN; CYCLOOXYGENASE 2; ISOENZYMES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; SULFONAMIDES; SULINDAC;

EID: 0242467932     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026199929747     Document Type: Article

References (18)

1. Williams CW, Dubois RN. Prostaglandin endoperoxide synthase: Why two isoforms? Am J Physiol 1996; 270: G393-G400.
2. Nathans D, Lau LF, Christy B, Hartzell S, Nakabeppu Y, Ryder K. Genomic response to growth factors. Cold Spring Harbor Symp Quant Biol 1988; 53: 893-900.
3. Herschman HR. Primary response genes induced by growth factors and tumor promoters. Ann Rev Biochem 1991; 60: 281-319.
4. Masferrer JL, Zweifel BS, Manning PT, et al. Selective inhibition of inducible cyclo-oxygenase-2 is antiinflammatory and non-ulcerogenic. Proc Natl Acad Sci USA 1994; 91: 3228-3232.
5. Sano H, Kawahito Y, Wilder R, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995; 55: 3785-3789.
6. Yang VW, Shields JM, Hamilton SR, et al. Size dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. Cancer Res 1998; 58: 1750-1753.
7. Boolbol SK, Dannenberg AJ, Chadburn A, et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 56: 2556-2560.
8. Marx J. Anti-inflammatories inhibit cancer growth - But how? Science 2001; 291: 581-582.
9. Piazza GA, Rahm AK, Finn TS, et al. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest and p53 induction. Cancer Res 1997; 57: 2452-2459.
10. Elder DJE, Halton DE, Hague A, Paraskeva C. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclo-oxygenase-2 selective non-steroidal anti-inflammatory drug: Independence from Cox-2 protein expression. Clin Can Res 1997; 3: 1679-1683.
11. Shureiqi I, Chen D, Lee JJ, et al. 15-LOX-1: A novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. Journal of the National Cancer Institute 2000; 92: 1136-1142.
12. Shureiqi I, Chen D, Lotan R, et al. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Research 2000; 60: 6846-6850.
13. Hsi LC, Angerman-Stewart J, Eling TE. Introduction of full length APC modulates cyclooxygenase-2 expression in HT29 human colorectal carcinoma cells at translational level. Carcinogenesis 1999; 20: 2045-2049.
14. Tsuji M, DuBois RN. Alteration in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995; 83: 493-501.
15. Li X, Darzynkiewicz Z. Labelling DNA strand breaks with BrdUTP. Detection of apoptosis and cell proliferation. Cell Proliferation 1995; 28: 572-579.
16. Moss SF, Agarwal B, Arber N, et al. Increased intestinal Bak expression results in apoptosis. Biochem Biophys Res Comm 1996; 223: 199-203.
17. Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in Human colon cancer cells. Cancer Res 1998; 58: 362-366.
18. Sheng H, Shao J, Kirkland SC, et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 1997; 99: 2254-2259.